Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Challenges in Patch Testing

Description

In a presentation by Dr. Chris Moad, challenges in patch testing were thoroughly discussed. Patch testing is crucial for identifying allergic reactions, but it involves numerous hurdles, including selecting the right time and method for testing, setting realistic expectations for patients, and ensuring optimal conditions for testing. Among the pre-testing challenges, healthcare professionals must accurately collect patient histories to identify potential allergens beyond the limited FDA-approved test options, which can miss significant allergens. Dr. Moad stressed the importance of detailed histories regarding patients’ exposure at work and personal care products. During testing, ensuring proper patch adhesion and managing skin conditions like dermatitis are vital. Post-testing, challenges arise from interpreting results—whether they are negative or positive. If negative, it may indicate the absence of an allergy or missed allergens, necessitating further exploration or diagnosis. For positive results, effective communication regarding allergen avoidance is imperative for better patient outcomes. The advent of tools like the CAMP database has improved patient education, allowing them to identify safe products and navigate product ingredients accurately. Lastly, staying updated with evolving allergens is essential, as the marketplace introduces new products regularly. Dr. Moad’s insights underscore the ongoing need for diligence in patch testing practices and patient education to enhance care and improve results.

View more

Conclusions

  • Patch testing is often necessary for patients with multifactorial dermatitis to identify underlying allergic reactions.
  • Providers must optimize testing conditions and educate patients about the expectations and processes of patch testing.
  • Many patients may experience flare-ups during patch testing, even if no allergens are identified.
  • Expanded allergen testing beyond the FDA-approved True Test can significantly improve diagnostic yields.
  • Documentation of thorough patient histories is crucial to uncover potential allergens.
  • Education on managing identified allergens is key to improving patient outcomes post-testing.
  • Two readings of patch tests are important to accurately distinguish between allergic and irritant reactions.
  • Understanding and staying current with emerging allergens is critical for effective patch testing.
  • Challenges such as immunosuppressive therapy can complicate patch testing but may still yield positive reactions in many cases
  • Accurate patient education and resource provision can greatly enhance the effectiveness of patch testing.
  • Dermatitis 2023:34 (2): 90-104.
  • Dermatitis 32(2): 111-123, 2021.
  • Dermatitis 24(1):7-9, 2013.
  • Dermatitis 28(2):141-143, 2017.
  • Dermatitis 31(5):279-282, 2020.
  • Dermatitis 23(6):301-302, 2012.
  • Dermatitis 32(6): 365-374, 2021.
  • JAAD in press.
  • JAAD 18:42-45. 1988. CD 24(2):119-122, 1991.
  • AJCD 8(4): 215-221,1997.
  • AJCD 9(3): 149-154, 1998.
  • Dermatitis 30(1):135-141, 2019.